Home

Scopia Management, Inc.

CIK 1665995 · last filed 2019-05-07

Scopia Management, Inc. is a corporate insider who has filed 32 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider sold $14.5M of ITRI on May 7, 2019. Across all open-market trades the lifetime net is −$123.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $397.4M across reported positions. The firm reports its address in New York, NY. 85 SEC filings were submitted jointly with JEREMY MINDICH.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$397.43M

Companies

2

Total Filings

32

Lifetime Open-Market Net

-$123.76M

Filer Profile

Reported Address
152 WEST 57TH STREET, 33RD FLOOR
NEW YORK, NY 10019
Phone
(212) 370-0303
State of Incorporation
NY
Related Filers
JEREMY MINDICH — 85 joint filings, latest 2019-05-30
SCOPIA CAPITAL MANAGEMENT LP — 85 joint filings, latest 2019-05-30
MATTHEW SIROVICH — 85 joint filings, latest 2019-05-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ITRI 10%+ Owner 4,096,766 $97.01 $397.43M -$23.19M 20 2019-05-07
Acorda Therapeutics, Inc. (ACOR) Delisted 10%+ Owner 39,585 $0.66 $26.2K -$100.57M 12 2019-02-01

Recent Filings

32 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-05-07 ITRI Sell (S) −267,240 -$14.49M EDGAR
2019-05-03 ITRI Sell (S) −276,376 -$14.71M EDGAR
2019-04-29 ITRI Sell (S) −114,564 -$5.88M EDGAR
2019-04-25 ITRI Sell (S) −122,380 -$6.29M EDGAR
2019-04-22 ITRI Sell (S) −55,028 -$2.75M EDGAR
2019-04-18 ITRI Sell (S) −169,332 -$8.46M EDGAR
2019-04-16 ITRI Sell (S) −245,420 -$11.90M EDGAR
2019-04-03 ITRI Other (J) −822,000 $0 EDGAR
2019-03-29 ITRI Sell (S) −130,896 -$6.05M EDGAR
2019-03-25 ITRI Sell (S) −232,184 -$11.60M EDGAR
Showing 1–10 of 32
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.